The plant extract industry has entered a transitional period

The transition period of EU traditional botanical medicine registration procedure directive expired on April 30, and Chinese patent medicine was blocked outside the EU market However, the East is not as bright as the West In recent years, the "natural wind" has been blowing in the international medical and health care products market The natural health care products are highly praised in the western developed countries, and its huge market space makes the plant extract become a hot product in the international market This year, China's export of plant extracts started well, with an import and export volume of about 520 million US dollars in the first five months, an increase of 45.7% year on year Among them, the export volume reached 450 million US dollars, a year-on-year increase of 49.4%, accounting for 47.5% of the export volume of traditional Chinese medicine, and the proportion of plant extracts in the export of traditional Chinese medicine products gradually increased Industry insiders said that the plant extract industry has entered a transition period after these years of development Whether the smooth transition from small and medium-sized enterprises to large enterprises can be achieved is the key factor to determine the healthy development of the industry in the future Zhang Chengwen, President of China plant extract association and general manager of Xi'an Haotian Bioengineering Technology Co., Ltd., has been engaged in the plant extract industry since 1995 and has a good understanding of the development trend of the whole industry He said that in recent years, the traditional export market of plant extracts in the United States has entered a stage of steady development, with an annual growth rate of about 5% The demand for plant extracts, especially natural pigments in emerging markets such as Spain and Mexico, has increased greatly The demand for natural pigments in the EU market is growing rapidly with an average annual growth rate of 35% Driven by these markets, plant extracts The export of goods will keep a good development trend China is recognized as a core player in the global health food industry In the next five years, China will become the largest market in the health food industry following the United States In the foreseeable future, the Chinese market will grow by 20% - 30% annually, and reach US $6.59 billion by 2020 Zhang Chengwen said that at first, due to the low threshold and low standard, the planting and lifting industry is dominated by small and medium-sized enterprises With the development of recent years, large enterprises focusing on quality and sustainable development are growing At present, there are about 10 enterprises above Designated Size in the export industry, and the export volume accounts for about 1 / 3 of the total export volume of the whole industry In Zhang Chengwen's view, one of the indicators for the industry to embark on a healthy development path is that more than 30 Enterprises above Designated Size have been established, which will take time At the same time, for the healthy and orderly development of the industry, Zhang also called on the relevant government departments to bring the planting industry into the scope of management as soon as possible, and change the status quo of "wide use, embarrassing identity" This year is the national "year of improving the quality of foreign trade commodities" The export enterprises of plant extracts actively responded to this and fulfilled their commitment to change the development mode of foreign trade through various measures Some companies continue to do well in the traditional market, but also strive to open up new markets to ensure the sustainable development of enterprises with market diversification Shandong Rongcheng Lily Biotechnology Co., Ltd exports its capsule products to more than 40 countries and regions around the world, and plans to sell its brand products through local sales channels in Vietnam, Bangladesh, Ukraine and other markets "Third class enterprises make products, second class enterprises make brands and first-class enterprises make standards", which is regarded as the "Bible" by Chenguang Biotechnology Group Co., Ltd to promote the development of the industry by participating in the formulation of product standards, such as the company's participation in the drafting of gb10783-2008 national standard for food additive chili red, national standard for lycopene, etc With the increasingly fierce competition among peers, differentiated competition has become the only way for enterprises to seek development Hangzhou baolingyangtaihe Biotechnology Co., Ltd has developed a new way of deep processing of bee products through the research and development of new technology Due to the large number of pollen production enterprises, there is not much profit to be made in the export process However, the export profit of active pollen polypeptide, a patented product developed by the company, can reach 40% Zhang Zhendong, general manager of the company, said that the company has more than 40 R & D personnel and will continue to explore the way of deep processing of bee products.